{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:50:49Z","timestamp":1755694249252,"version":"3.41.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijcrp.2025.200400","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T08:16:36Z","timestamp":1743927396000},"page":"200400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reducing premature mortality from cardiovascular diseases in low and middle income countries: The role of Polypill in public health policy"],"prefix":"10.1016","volume":"25","author":[{"given":"Sadaf G.","family":"Sepanlou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-0891","authenticated-orcid":false,"given":"SeyedehFatemeh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-6335","authenticated-orcid":false,"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2025.200400_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: projections from 2025 to 2050","author":"Chong","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2025.200400_bib4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(22)01847-5","article-title":"The polypill: from concept and evidence to implementation","volume":"400","author":"Yusuf","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1815359","article-title":"Polypill for cardiovascular disease prevention in an underserved population","volume":"381","author":"Mu\u00f1oz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.ijcrp.2025.200400_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41591-021-01635-9","article-title":"Polypills for the prevention of cardiovascular disease: a framework for wider use","volume":"28","author":"Patel","year":"2022","journal-title":"Nat. Med."},{"article-title":"Web annex A. World health organization model list of essential medicines \u2013 23rd list","year":"2023","series-title":"The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24 \u2013 28 April 2023","key":"10.1016\/j.ijcrp.2025.200400_bib8"},{"key":"10.1016\/j.ijcrp.2025.200400_bib9","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1186\/s12889-024-19583-7","article-title":"Causes and predictors of premature death in the pars cohort study, Iran: a cohort study","volume":"24","author":"Ziamanesh","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijcrp.2025.200400_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021479","article-title":"Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran","volume":"8","author":"Nalini","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcrp.2025.200400_bib11","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)02751-3","article-title":"Health system performance in Iran: a systematic analysis for the global burden of disease study 2019","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12961-021-00800-3","article-title":"Challenges and opportunities for Iranian global health diplomacy: lessons learned from action for prevention and control of noncommunicable diseases","volume":"19","author":"Asadi-Lari","year":"2021","journal-title":"Health Res. Pol. Syst."},{"key":"10.1016\/j.ijcrp.2025.200400_bib14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2018.07.012","article-title":"The International Polycap Study-3 (TIPS-3): design, baseline characteristics and challenges in conduct","volume":"206","author":"Joseph","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200400_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(21)01827-4","article-title":"Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis","volume":"398","author":"Joseph","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/heartjnl-2022-322278","article-title":"Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis","volume":"109","author":"Dagenais","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ijcrp.2025.200400_bib22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/eurjpc\/zwad245","article-title":"Polypill-based strategy vs. usual care for secondary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Rivera","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2025.200400_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.34172\/aim.2020.58","article-title":"Effectiveness of polypill for prevention of cardiovascular disease (PolyPars): protocol of a randomized controlled trial","volume":"23","author":"Malekzadeh","year":"2020","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/heartjnl-2023-323614","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)","author":"Malekzadeh","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.ijcrp.2025.200400_bib25","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200400_bib26","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcrp.2025.200400_bib27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijcrp.2025.200400_bib28","first-page":"515","article-title":"PolyPill for prevention of cardiovascular disease in an urban Iranian population with special focus on nonalcoholic steatohepatitis: a pragmatic randomized controlled trial within a cohort (PolyIran - liver) - study protocol","volume":"18","author":"Merat","year":"2015","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.ijcrp.2025.200400_bib29","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/eurheartj\/ehab919","article-title":"Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial","volume":"43","author":"Merat","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200400_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s12072-023-10542-9","article-title":"Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trial","volume":"17","author":"Ramandi","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijcrp.2025.200400_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200400_bib32","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2215\/CJN.0000000000000251","article-title":"Fixed-dose combination therapy for the prevention of cardiovascular diseases in CKD: an individual participant data meta-analysis","volume":"18","author":"Sepanlou","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcrp.2025.200400_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271908","article-title":"Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: a systematic literature review","volume":"17","author":"Jahangiri","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2025.200400_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102651","article-title":"Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysis","volume":"73","author":"Lamy","year":"2024","journal-title":"eClinicalMedicine"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:23:59Z","timestamp":1749011039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S2772487525000388"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200400","relation":{},"ISSN":["2772-4875"],"issn-type":[{"type":"print","value":"2772-4875"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing premature mortality from cardiovascular diseases in low and middle income countries: The role of Polypill in public health policy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200400"}}